Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)91

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)27

Views

Views
December 20252
January 20262
February 20261
March 20267
April 20266
May 20265
June 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States18
Colombia2
Argentina1
Canada1
Côte d'Ivoire1
United Kingdom1
Netherlands1
Venezuela1
South Africa1
 

Top cities views

Views
San Jose3
Ashburn1
Barquisimeto1
Cape Town1
Dallas1
Groningen1
Kerrville1
London1
Memphis1
Pereira1